HIV disease progression: Depression, stress, and possible mechanisms

Biological Psychiatry

Volumn 54, Issue 3, 2003, Pages 295-306

  Leserman, Jane ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Cortisol; Depression; Human immunodeficiency virus; Psychoneuroimmunology; Stress; Sympathetic nervous system

Indexed keywords

ANTIRETROVIRUS AGENT; CATECHOLAMINE; CD16 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CORTICOTROPIN; CYTOKINE; GLUCOCORTICOID; NEOPTERIN; NORADRENALIN; PHYTOHEMAGGLUTININ; PRASTERONE; SUBSTANCE P; SUBSTANCE P ANTAGONIST;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BEREAVEMENT; BIOLOGY; BRAIN DYSFUNCTION; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; HEALTH BEHAVIOR; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFECTION RISK; INJURY; LIFE EVENT; MACROPHAGE; MORTALITY; NATURAL KILLER CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SOCIAL PROBLEM; STRESS; SURVIVAL; T LYMPHOCYTE; VIRUS LOAD; IMMUNOLOGY; MENTAL STRESS; METABOLISM; PSYCHOLOGICAL ASPECT;

CATECHOLAMINES; DEPRESSION; DISEASE PROGRESSION; GLUCOCORTICOIDS; HIV INFECTIONS; HUMANS; STRESS, PSYCHOLOGICAL; SUBSTANCE P;

EID: 0141832607     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00323-8     Document Type: Review

References (89)

1. Anand A., Charney D.S. Norepinephrine dysfunction in depression. J Clin Psychiatry. 61:(suppl 10):2000;16-24.
2. Anonymous (1992): 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 41(RR-17):1-19.
3. Antoni M.H., Cruess D.G., Cruess S., Lutgendorf S., Kumar M., Ironson G., et al. Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol. 68:2000;31-45.
4. Antoni M.H., Schneiderman N., Klimas N., LaPerriere A., Ironson G., Fletcher M.A. Disparities in psychological, neuroendocrine, and immunologic patterns in asymptomatic HIV-1 seropositive and seronegative gay men. Biol Psychiatry. 29:1991;1023-1041.
5. Bandyopadhyay S., Ziegner U., Campbell D.E., Miller D.S., Hoxie J.A., Starr S.E. Natural killer cell mediated lysis of T cell lines chronically infected with HIV-1. Clin Exp Immunol. 79:1990;430-435.
6. Barker E. CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor. J Infect Dis. 179:(suppl 3):1999;S485-S488.
7. Bower J.E., Kemeny M.E., Taylor S.E., Fahey J.L. Cognitive processing discovery of meaning CD4 decline and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol. 66:1998;979-986.
8. Bruce M. Psychological risk factors for depressive disorders in late life. Biol Psychiatry. 52:2002;175-184.
9. Burack J.H., Barrett D.C., Stall R.D., Chesney M.A., Ekstrand M.L., Coates T.J. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 270:1993;2568-2573.
10. Capitanio J.P., Mendoza S.P., Lerche N.W., Mason W.A. Social stress results in altered glucocorticoid regulation and shorter survival in simian acquired immune deficiency syndrome. Proc Natl Acad Sci U S A. 95:1998;4714-4719.
11. Christeff N., Gherbi N., Mammes O., Dalle M.T., Gharakhanian S., Lortholary O., et al. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology. 22:(suppl 1):1997;S11-S18.
12. Clerici M., Trabattoni D., Piconi S., Fusi M.L., Ruzzante S., Clerici C., Villa M.L. A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology. 22: (suppl 1):1997;S27-S31.
13. Cole S.W., Kemeny M.E. Psychobiology of HIV infection. Crit Rev Neurobiol. 11:1997;289-321.
14. Cole S.W., Korin Y.D., Fahey J.L., Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol. 161:1998;610-616.
15. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., Fahey J.L., Zack J.A. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A. 98:2001;12695-12700.
16. Corley P.A. Acquired immune deficiency syndrome The glucocorticoid solution . Med Hypotheses. 47:1996;49-54.
17. Cruess D.G., Antoni M.H., Kumar M., Ironson G., McCabe P., Fernandez J.B., et al. Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men. Psychoneuroendocrinology. 24:1999;537-549.
18. Cruess D.G., Antoni M.H., Kumar M., Schneiderman N. Reductions in salivary cortisol are associated with mood improvement during relaxation training among HIV-seropositive men. J Behav Med. 23:2000;107-122.
19. Cruess S., Antoni M., Cruess D., Fletcher M.A., Ironson G., Kumar M., et al. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med. 62:2000;828-837.
20. Cupps T.R., Fauci A.S. Corticosteroid-mediated immunoregulation in man. Immunol Rev. 65:2002;133-155.
21. Daynes R.A., Araneo B.A., Hennebold J., Enioutina E., Mu H.H. Steroids as regulators of the mammalian immune response. J Invest Dermatol. 105:(1 suppl):1995;14S-19S.
22. Daynes R.A., Meikle A.W., Araneo B.A. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol. 142:1991;40-45.
23. Dimsdale J.E., Ziegler M.G. What do plasma and urinary measures of catecholamines tell us about human response to stressors? Circulation. 83:(4 suppl):1991;II36-II42.
24. Douglas S.D., Ho W.Z., Gettes D.R., Cnaan A., Zhao H., Leserman J., et al. Elevated substance P levels in HIV-infected men. AIDSs. 15:2001;2043-2045.
25. Eich-Hochli E., Niklowitz M.W., Luthy R., Opravil M. Are immunological markers, social and personal resources, or a complaint-free state predictors of progression among HIV-infected patients? Acta Psychiatr Scand. 95:1997;476-484.
26. Evans D.L., Leserman J., Golden R.N., Lewis M.H., Folds J.A., Ozer H. Immune correlates of stress and depression. Psychopharmacol Bull. 25:1989;319-324.
27. Evans D.L., Leserman J., Perkins D.O., Stern R.A., Murphy C., Tamul K., et al. Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection. Am J Psychiatry. 152:1995;543-550.
28. Evans D.L., Leserman J., Perkins D.O., Stern R.A., Murphy C., Zheng B., et al. Severe life stress as a predictor of early disease progression in HIV infection. Am J Psychiatry. 154:1997;630-634.
29. Evans D.L., Ten Have T.R., Douglas S.D., Gettes D., Morrison C.H., Chiappini M.S., et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 10:2002;1-8.
30. Famularo G., Moretti S., Marcellini S., Nucera E., De Simone C. CD8 lymphocytes in HIV infection Helpful and harmful . J Clin Lab Immunol. 49:1997;15-32.
31. Fawzy F.I., Fawzy N.W., Hyun C.S., Elashoff R., Guthrie D., Fahey J.L., Morton D.L. Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 50:1993;681-689.
32. Friedman E.M., Irwin M.R. Modulation of immune cell function by the autonomic nervous system. Pharmacol Ther. 74:1997;27-38.
33. Giorgi J.V., Hultin L.E., McKeating J.A., Johnson T.D., Owens B., Jacobson L.P., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 179:1999;859-870.
34. Goodkin K., Baldewicz T.T., Asthana D., Khamis I., Blaney N.T., Kumar M., et al. A bereavement support group intervention affects plasma burden of human immunodeficiency virus type 1. Report of a randomized controlled trial. J Hum Virol. 4:2001;44-54.
35. Goodkin K., Feaster D.J., Asthana D., Blaney N.T., Kumar M., Baldewicz T., et al. A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits. Clin Diagn Lab Immunol. 5:1998;382-391.
36. Goodkin K., Feaster D.J., Tuttle R., Blaney N.T., Kumar M., Baum M.K., et al. Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men. Clin Diagn Lab Immunol. 3:1996;109-118.
37. Gorman J.M., Kertzner R., Cooper T., Goetz R.R., Lagomasino I., Novacenko H., et al. Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. Am J Psychiatry. 148:1991;41-45.
38. Graziosi C., Pantaleo G., Gantt K.R., Fortin J.P., Demarest J.F., Cohen O.J., Sekaly R.P. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science. 265:1994;248-252.
39. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
40. Herbert T.B., Cohen S. Depression and immunity A meta-analytic review . Psychol Bull. 113:1993;472-486.
41. Herbert T.B., Cohen S. Stress and immunity in humans A meta-analytic review . Psychosom Med. 55:1993;364-379.
42. Ho H.N., Hultin L.E., Mitsuyasu R.T., Matud J.L., Hausner M.A., Bockstoce D., et al. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol. 150:1993;3070-3079.
43. Ho W.Z., Cnaan A., Li Y.H., Zhao H., Lee H.R., Song L., Douglas S.D. Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res Hum Retroviruses. 12:1996;195-198.
44. Hokfelt T., Pernow B., Wahren J. Substance P A pioneer amongst neuropeptides . J Intern Med. 249:2001;27-40.
45. Howland L.C., Gortmaker S.L., Mofenson L.M., Spino C., Gardner J.D., Gorski H., et al. Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1. Pediatrics. 106:2000;540-546.
46. Ickovics J.R., Hamburger M.E., Vlahov D., Schoenbaum E.E., Schuman P., Boland R.J., Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women Longitudinal analysis from the HIV Epidemiology Research Study . JAMA. 285:2001;1460-1465.
47. Ironson G., Balbin E., Solomon G., Fahey J., Klimas N., Schneiderman N., Fletcher M.A. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS. 15:2001;2065-2073.
48. Ironson G., Friedman A., Klimas N., Antoni M., Fletcher M.A., LaPerriere A., et al. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med. 1:1994;90-105.
49. Irwin M., Hauger R.L., Jones L., Provencio M., Britton K.T. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther. 255:1990;101-107.
50. Kemeny M.E., Dean L. Effects of AIDS-related bereavement on HIV progression among New York City gay men. AIDS Educ Prev. 7:(5 suppl):1995;36-47.
51. Kemeny M.E., Weiner H., Duran R., Taylor S.E., Visscher B., Fahey J.L. Immune system changes after the death of a partner in HIV-positive gay men. Psychosom Med. 57:1995;547-554.
52. Kertzner R.M., Goetz R., Todak G., Cooper T., Lin S.H., Reddy M.M., et al. Cortisol levels, immune status, and mood in homosexual men with and without HIV infection. Am J Psychiatry. 150:1993;1674-1678.
53. Kessler R.C., Foster C., Joseph J., Ostrow D., Wortman C., Phair J., Chmiel J. Stressful life events and symptom onset in HIV infection. Am J Psychiatry. 148:1991;733-738.
54. Kimerling R., Calhoun K.S., Forehand R., Armistead L., Morse E., Morse P., et al. Traumatic stress in HIV-infected women. AIDS Educ Prev. 11:1999;321-330.
55. Leserman J., DiSantostefano R., Perkins D.O., Murphy C., Golden R.N., Evans D.L. Longitudinal study of social support and social conflict as predictors of depression and dysphoria among HIV-positive and HIV-negative men. Depression. 2:1994;189-199.
56. Leserman J., Jackson E.D., Petitto J.M., Golden R.N., Silva S.G., Perkins D.O., et al. Progression to AIDS The effects of stress, depressive symptoms, and social support . Psychosom Med. 61:1999;397-406.
57. Leserman J., Petitto J.M., Golden R.N., Gaynes B.N., Gu H., Perkins D.O., et al. The impact of stressful life events, depression, social support, coping and cortisol on progression to AIDS. Am J Psychiatry. 157:2000;1221-1228.
58. Leserman J., Petitto J.M., Gu H., Gaynes B.N., Barroso J., Golden R.N., et al. Progression to AIDS, a clinical AIDS condition, and mortality Psychosocial and physiological predictors . Psychol Med. 32:2002;1059-1073.
59. Leserman J., Petitto J.M., Perkins D.O., Folds J.D., Golden R.N., Evans D.L. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. Arch Gen Psychiatry. 54:1997;279-285.
60. Liu Z., Cumberland W.G., Hultin L.E., Kaplan A.H., Detels R., Giorgi J.V. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr. 18:1998;332-340.
61. Lutgendorf S.K., Antoni M., Ironson G., Starr K., Costello N., Zuckerman M., et al. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosom Med. 60:1998;204-214.
62. Lyketsos C.G., Hoover D.R., Guccione M. Depression and survival among HIV-infected persons. JAMA. 275:1996;35-36.
63. Lyketsos C.G., Hoover D.R., Guccione M., Dew M.A., Wesch J.E., Bing E.G., Treisman G.J. Changes in depressive symptoms as AIDS develops. Am J Psychiatry. 153:1996;1430-1437.
64. Lyketsos C.G., Hoover D.R., Guccione M., Senterfitt W., Dew M.A., Wesch J., et al. Depressive symptoms as predictors of medical outcomes in HIV infection. JAMA. 270:1993;2563-2567.
65. Maggi E., Mazzetti M., Ravina A., Annunziato F., de Carli M., Piccinni M.P., et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 265:1994;244-248.
66. Markham P.D., Salahuddin S.Z., Veren K., Orndorff S., Gallo R.C. Hydrocortisone and some other hormones enhance the expression of HTLV-III. Int J Cancer. 37:1986;67-72.
67. Mayne T.J., Vittinghoff E., Chesney M.A., Barrett D.C., Coates T.J. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med. 156:1996;2233-2238.
68. Mulder C.L., Emmelkamp P.M., Antoni M., Mulder J.W., Sandfort T.G., de Vries M.J. Cognitive-behavioral and experiential group psychotherapy for HIV-infected homosexual men A comparative study . Psychosom Med. 56:1994;423-431.
69. Nair M.P., Saravolatz L.D., Schwartz S.A. Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lymphocytes from AIDS patients. Immunol Invest. 24:1995;689-699.
70. O'Brien K.O., Wortman C.B., Kessler R.C., Joseph J.G. Social relationships of men at risk for AIDS. Soc Sci Med. 36:1993;1161-1167.
71. Oliva A., Kinter A.L., Vaccarezza M., Rubbert A., Catanzaro A., Moir S., et al. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest. 102:1998;223-231.
72. Page-Shafer K., Delorenze G.N., Satariano W., Winkelstein W. Jr. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol. 6:1996;420-430.
73. Patterson T.L., Semple S.J., Temoshok L.R., Atkinson J.H., McCutchan J.A., Straits-Troster K., et al. Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. Psychiatry. 58:1995;299-312.
74. Patterson T.L., Shaw W.S., Semple S.J., Cherner M., Nannis E., McCutchan J.A., et al. Relationship of psychosocial factors to HIV disease progression. Ann Behav Med. 18:1996;30-39.
75. Perkins D.O., Stern R.A., Golden R.N., Murphy C., Naftolowitz D., Evans D.L. Mood disorders in HIV infection Prevalence and risk factors in a non-epicenter of the AIDS epidemic . Am J Psychiatry. 151:1994;233-236.
76. Perry S., Fishman B., Jacobsberg L., Frances A. Relationships over one-year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry. 49:1992;396-401.
77. Petitto J.M., Leserman J., Perkins D.O., Stern R.A., Silva S.G., Gettes D., et al. High versus low basal cortisol secretion in asymptomatic, medication-free HIV infected men Differential effects of severe life stress on parameters of immune status . Behav Med. 25:2000;143-151.
78. Price D.A., O'Callaghan C.A., Whelan J.A., Easterbrook P.J., Phillips R.E. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection. Clin Sci. 97:1999;707-718.
79. Rabkin J.G., Williams J.B.W., Remien R.H., Goetz R.R., Dertzner R., Gorman J.M. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry. 48:1991;111-119.
80. Radloff L.S. The CES-D scale A self-report depression scale for research in the general population . Appl Psychol Measures. 1:1977;386-401.
81. Ramirez A.J., Craig T.J.K., Watson J.P., Fentiman I.S., North W.R.S., Rubens R.D. Stress and relapse of breast cancer. Br Med J. 298:1989;291-293.
82. Spiegel D., Kraemer H.C., Bloom J.R., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 2:1989;888-891.
83. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R: Nonpatient Edition (SCID-NP). 1990;American Psychiatric Press, Washington, DC.
84. Stein M., Miller A.H., Trestman R.L. Depression, the immune system and health and illness. Arch Gen Psychiatry. 48:1991;171-177.
85. Ullum H., Cozzi L.A., Aladdin H., Katzenstein T., Victor J., Phillips A.N., et al. Natural immunity and HIV disease progression. AIDS. 13:1999;557-563.
86. Vago T., Clerici M., Norbiato G. Glucocorticoids and the immune system in AIDS. Baillieres Clin Endocrinol Metab. 8:1994;789-802.
87. Vedhara K., Schifitto G., McDermott M. Disease progression in HIV-positive women with moderate to severe immunosuppression The role of depression. Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders . Behav Med. 25:1999;43-47.
88. Ward M.M., Mefford I.N., Parker S.D., Chesney M.A., Taylor C.B., Keegan D.L., Barchas J.D. Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors. Psychosom Med. 45:1983;471-486.
89. Weisse C.S. Depression and immunocompetence A review of the literature . Psychol Bull. 111:1992;475-489.